Iodo benzene diacetate → HCID 71005110, compound
Reaction equation
[CH:1]1([CH2:4][O:5][C:6]2[CH:7]=[CH:8][CH:9]=[C:10]3[C:15]=2[N:14]=[C:13]([CH:16]=O)[CH:12]=[CH:11]3)[CH2:3][CH2:2]1.[CH3:18][N:19]([C@H:27]1[CH2:31][CH2:30][N:29]([CH:32]([C:37]2[CH:38]=[N:39][C:40]([NH:43][NH2:44])=[CH:41][CH:42]=2)[C:33]([F:36])([F:35])[F:34])[CH2:28]1)C(=O)OC(C)(C)C.C(O)(=O)C.C(O)(=O)C.IC1C=CC=CC=1>C(O)C.CC#N>[CH:1]1([CH2:4][O:5][C:6]2[CH:7]=[CH:8][CH:9]=[C:10]3[C:15]=2[N:14]=[C:13]([C:16]2[N:39]4[CH:38]=[C:37]([CH:32]([N:29]5[CH2:30][CH2:31][C@H:27]([NH:19][CH3:18])[CH2:28]5)[C:33]([F:34])([F:36])[F:35])[CH:42]=[CH:41][C:40]4=[N:43][N:44]=2)[CH:12]=[CH:11]3)[CH2:3][CH2:2]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 8-(cyclopropylmethoxy)quinoline-2-carbaldehyde (0.14 g, 0.62 mmol) and tert-butyl methyl((3S)-1-(2,2,2-trifluoro-1-(6-hydrazinylpyridin-3-yl)ethyl)pyrrolidin-3-yl)carbamate (0.20 g, 0.51 mmol) in ethanol (10 mL) was stirred at ambient temperature for 16 hours. The solvent was removed under reduced pressure. The residue was dissolved in dichloromethane (10 mL) and treated with iodobenzene diacetate (0.20 g, 0.62 mmol) and stirred at ambient temperature for 4 hours. The mixture was partitioned between ethyl acetate (20 mL) and saturated sodium bicarbonate solution (10 mL). The organic layer was separated, washed with brine, dried (MgSO4, filtered and concentrated under reduced pressure. The residue was purified by reverse phase chromatography (Biotage SP4, C-18 25M; 10-90% CH3CN/water gradient). The residue was dissolved in dichloromethane (1 mL), treated with TFA (4 mL) and stirred at ambient temperature for 1 hour. The solution was concentrated under reduced pressure and the residue was purified by reverse phase chromatography (Biotage SP4, C-18 25M; 10-70% CH3CN/water gradient). The TFA salt was dissolved in methanol (0.50 mL) and treated with 2N HCl in diethyl ether (4 mL) and stirred for 10 minutes. The solvent was removed under reduced pressure and the solid obtained suspended in MeCN (5 mL) and stirred for 10 minutes. The solid was collected by filtration to afford (3S)-1-(1-(3-(8-(cyclopropylmethoxy)quinolin-2-yl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-2,2,2-trifluoroethyl)-N-methylpyrrolidin-3-amine (0.129 g, 44%). LCMS APCI (+) m/z 497 (M+H).
Workup
- customThe solvent was removed under reduced pressure
- dissolutionThe residue was dissolved in dichloromethane (10 mL)
- customThe mixture was partitioned between ethyl acetate (20 mL) and saturated sodium bicarbonate solution (10 mL)
- customThe organic layer was separated
- washwashed with brine
- dry with materialdried (MgSO4
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customThe residue was purified by reverse phase chromatography (Biotage SP4
- dissolutionThe residue was dissolved in dichloromethane (1 mL)
- additiontreated with TFA (4 mL)
- stirringstirred at ambient temperature for 1 hour
- concentrationThe solution was concentrated under reduced pressure
- customthe residue was purified by reverse phase chromatography (Biotage SP4
- dissolutionThe TFA salt was dissolved in methanol (0.50 mL)
- additiontreated with 2N HCl in diethyl ether (4 mL)
- stirringstirred for 10 minutes
- customThe solvent was removed under reduced pressure
- customthe solid obtained
- stirringstirred for 10 minutes
- filtrationThe solid was collected by filtration
Sources & evidence
- ORD record
- ord-acd4c47d80ed4d8fab1aee879662465e
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08889704B2
Reaction notes
Loading…